Cardeon’s management team has significant entrepreneurial experience
Substantial experience in research, medical, medtech and biotechnical sectors. Solid entrepreneurial experience and expertise within applied medicine, microbiology and biotechnology.
Fredrik is a visionary and has been an active entrepreneur and investor for many years. Founder of Virtway Invest Ltd. He was previously a stockbroker.
Board member & CEO
Roger Jensen, entrepreneur and investor with a breadth of experience of financing and developing companies at an early stage. He has 15 years’ experience of distribution, marketing and sales.
Substitute board member
Significant experience of commercialising research findings as CTO at SpectaCure and before that CTO at Gasporox and GPX Medical. Expert knowledge of product development in medical technology systems.
Katarina Svanberg is M.D., PhD and has long been a consultant and adjunct professor of oncology at Lund University. She has been a part-time professor since 2011 at South China Normal University in Guangzhou, China. Katarina has introduced photodynamic tumor therapy in clinical use at Lund University Hospital. She has received the American Medicines Agency’s award in laser medicine, and the optics and laser organization SPIE’s highest reward; its gold medal. Katarina is a board member of the Lund Laser Center and has served since 1993, first as director and now as chairman of the board of Lund University Medical Laser Center.
Sune Svanberg is a senior professor of physics at Lund University. He has been director of the Department of Nuclear Physics for 30 years and of the Lund Laser Center for 15 years, and member of the Nobel Committee in Physics for 10 years. Sune has been awarded around 20 international and national awards and holds five honorary doctorates and four honorary professorships. Since 2011, Sune also holds a part-time professorship at South China Normal University, Guangzhou, China.
Professor of Physics at Lund University up until 2016. Since 2016 Director of Biophotonics at Tyndall National Institute, Ireland. Postdoc at McMasters University in Hamilton, Ontario, Canada. Received the Erna Ebelings award, Swedish Society for Medical Technology and Physics, 2003. Co-author of more than 200 published peer-reviewed articles.
Bachelor of Science in Chemistry and Biology, Doctor of Physiology from Uppsala University, and Associate Professor at Uppsala University. Consultant in biotechnology and finance. Previously worked on research and business development at both Astra AB and Pharmacia AB. Thereafter, as a pharmaceutical analyst in the financial industry, such as at Swedbank, Aros Securities and ABG Sundal Collier. Today, the Chairman of the Board of, among others, Miris Holding, SpectraCure and EQL Pharma.
Professor of Surgery at Lund University since 2000. Solid clinical experience, and clinical and translational research. Author of more than 500 published peer-reviewed articles. Supervisor for some 30 PhD graduate students in the areas of cancer, systemic inflammation, organ failure and bowel function.
Medical candidate from Karolinska Institutet, MBA from Stockholm School of Economics. Currently a partner at Rewell Medical AB. Previously been General Manager, Vice President of EMEA at Hycor Biomedical, Vice President Commercial Operations Europe at Thermo Fisher Scientific Immuno Diagnostics Division.